Metagenomics, the Microbiome, and Alcohol Use Disorder: What We Know—and What We Don’t
In recent years, the human microbiome has been marketed as the missing key to everything from mood to metabolism to addiction. Functional medicine clinics now routinely offer microbiome testing, promising personalized insights and targeted treatment plans.
There is some real science here—*but also real overreach.
To understand where things stand, we need to separate what’s promising from what’s proven.
What Is the Microbiome?
The microbiome refers to the trillions of microorganisms—bacteria, viruses, fungi—that live in and on the human body, especially in the gut.
These organisms are not just passive passengers. They play roles in:
- Digestion
- Immune function
- Inflammation regulation
- Communication with the brain (often called the gut–brain axis)
(This last point is where much of the excitement—and confusion—comes from.)
What Is Metagenomics?
Metagenomics is the method scientists use to study the microbiome.
Instead of trying to grow bacteria in a lab (which, btw. misses most species), metagenomics analyzes genetic material directly from stool or other samples. This allows researchers to:
- Identify which microbes are present
- Estimate their relative abundance
- Infer potential biological functions
That sounds powerful—and it is—but there’s a catch.
The Problem with Microbiome Testing (Especially in Functional Medicine)
Many functional medicine practices sell stool-based microbiome tests as if they provide precise, actionable clinical data.
They don’t.
At least not yet.
…and here’s why:
1. Lack of Standardization
Different labs use different sequencing methods, databases, and algorithms. The same sample sent to two labs can produce meaningfully different results.
2. “Normal” Isn’t Well Defined
There is no single “healthy microbiome.” What’s normal varies widely based on:
- Diet
- Geography
- Age
- Genetics
So labeling bacteria as “good” or “bad” is often an oversimplification.
3. Correlation ≠ Causation
Much of microbiome science is observational. Just because a certain bacterial pattern is associated with a condition doesn’t mean it caused it.
4. Limited Clinical Actionability
Even when differences are identified, there is often no evidence-based intervention that reliably “fixes” them.
Bottom line: These tests can generate interesting data, but they are often presented with a level of certainty that the science does not support.
Microbiome Dysbiosis: A Real Concept—But Easy to Misuse
Dysbiosis refers to an imbalance in the microbial community.
This is a legitimate concept and has been linked to:
- Inflammatory conditions
- Gastrointestinal disorders
- Metabolic disease
But dysbiosis is not a single disease—and it is not easily reduced to a lab score.
The Gut–Brain Axis and Neurochemistry
The gut and brain communicate constantly through what’s known as the Gut–brain axis.
Gut microbes can influence the production and regulation of key neurotransmitters:
- Serotonin (about 90% is produced in the gut)
- Dopamine
- Gamma-aminobutyric acid (inhibitory/calming)
This is where things begin to intersect with addiction.
Alcohol Use Disorder and the Microbiome
Alcohol Use Disorder (AUD) is not just a behavioral issue—it’s a complex brain and body disorder.
Chronic alcohol use:
- Damages the gut lining (“leaky gut”)
- Alters microbial composition
- Increases systemic inflammation
- Disrupts liver function
These changes reinforce each other in a feedback loop.
The Liver Connection
The gut and liver are directly connected via the portal vein. This is sometimes referred to as the gut–liver axis.
When alcohol disrupts the microbiome:
Harmful bacterial byproducts (like endotoxins) can enter circulation. These reach the liver and trigger inflammation.
This contributes to conditions like:
- Alcoholic Liver Disease
- Fatty liver
- Hepatitis
- Cirrhosis
So while microbiome changes don’t cause liver disease on their own, they can significantly worsen it.
Neurochemistry, Dysbiosis, and Addiction Risk
Here’s where we need to be careful—but also honest.
There is emerging evidence that microbiome disruption may influence neurotransmitter systems involved in addiction.
A simplified model looks like this:
1. Decreased Serotonin
Associated with low mood, anxiety, irritability Increases vulnerability to using alcohol for emotional regulation
2. Decreased Dopamine
Reduced reward sensitivity Leads to seeking stronger stimuli (like alcohol) to feel “normal”
3. Increased GABA Activity (or dysregulated GABA signaling)
Alcohol enhances GABA’s calming effects Over time, the brain adapts, creating dependence
Together, this pattern can:
- Increase cravings
- Reduce stress tolerance
- Reinforce compulsive use
Now here’s the important reality check:
We do not yet have evidence that fixing the microbiome alone can correct these neurotransmitter imbalances in a clinically reliable way. But that doesn’t stop some from claiming it does anyway. That’s where the current hype gets ahead of the science.
Where Functional Medicine Often Gets It Wrong
To be fair, functional medicine has helped push attention toward systems thinking and root causes.
But in the case of microbiome testing, there are consistent problems:
- Overstating precision of tests
- Overinterpreting weak or associative data
- Selling expensive, long supplement protocols with limited evidence
- Suggesting that microbiome correction can significantly treat complex conditions like AUD
*That last point is particularly concerning.
What Actually Helps in Alcohol Use Disorder
If someone is struggling with AUD, focusing primarily on microbiome testing is, at best, a distraction—and at worst, a delay in receiving effective care.
Evidence-based treatment includes:
- Medical evaluation and detox when needed
- Medications that reduce cravings
- Psychotherapy and behavioral treatment
- Social and community support
Improving gut health can be supportive:
- Nutrition
- Reducing alcohol exposure (the biggest factor)
- Addressing inflammation
But it is not a standalone treatment.
A Balanced Take
The microbiome is real. Metagenomics is a powerful research tool. Dysbiosis likely plays a role in many chronic conditions, including those related to alcohol use.
But we are still early in translating this science into reliable, individualized clinical care.
Right now:
- The science is promising
- The testing is inconsistent
- The clinical applications are limited
- The marketing is ahead of the evidence
Wrap It All Up
If you or someone you love is dealing with alcohol use disorder, it’s understandable to look for deeper explanations and more personalized solutions. Just be careful not to confuse interesting biology with proven treatment.
The microbiome may be part of the story—but it is not the whole story.
*And in addiction care, focusing on what works today is far more important than chasing what might work someday.